Epilepsy trials in Belgium: Trial Insights

Filters: Condition: Epilepsy Country / region: Belgium Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year
Category	Trials
2004	2
2005	7
2006	5
2007	5
2008	8
2009	2
2010	5
2011	10
2012	2
2013	6
2014	6
2015	5
2016	6
2017	4
2018	4
2019	7
2020	4
2021	7
2022	2
2023	5
2024	5
2025	3

Trials by status
Category	Trials
Completed	69
Terminated	15
Recruiting	7
Unknown status	7
Active, not recruiting	6
Enrolling by invitation	4
Withdrawn	2

Top lead sponsors
Category	Trials
University Hospital, Ghent	13
UCB Pharma	12
Eisai Inc.	7
Universitaire Ziekenhuizen KU Leuven	7
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	6
Cyberonics, Inc.	5
Xenon Pharmaceuticals Inc.	5
GlaxoSmithKline	4
UCB BIOSCIENCES, Inc.	4
UCB Pharma SA	4

Top conditions
Category	Trials
Epilepsy	110
Seizures	33
Epilepsies, Partial	13
Drug Resistant Epilepsy	9
Epilepsies, Myoclonic	5
Brain Diseases	4
Lennox Gastaut Syndrome	3
Neurodevelopmental Disorders	3
Brain Neoplasms	2
Central Nervous System Diseases	2

Trials

Showing 76 to 100 of 110. Each trial links to its page on Pharma Observatory.

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated NCT01281293ObservationalCompletedCyberonics, Inc.Started 2011
Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures NCT01261325Phase 3CompletedUCB PharmaStarted 2010
Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures NCT01191086Phase 3CompletedUpsher-Smith LaboratoriesStarted 2010
A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents NCT01161524Phase 2CompletedEisai Inc.Started 2010
Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures NCT01227902Phase 3CompletedGlaxoSmithKlineStarted 2010
Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures NCT01142193Phase 3CompletedUpsher-Smith LaboratoriesStarted 2010
An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy NCT00938912Phase 2CompletedUCB BIOSCIENCES, Inc.Started 2009
A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures NCT00938431Phase 2CompletedUCB PharmaStarted 2009
Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study) NCT00566254Phase 3CompletedEisai Inc.Started 2008
ADX10059 Migraine Prevention Study NCT00820105Phase 2TerminatedAddex Pharma S.A.Started 2008
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures NCT00988429Phase 3CompletedBial - Portela C S.A.Started 2008
An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam NCT00761774Phase 3CompletedUCB PharmaStarted 2008
Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine NCT00900237Phase 1CompletedBial - Portela C S.A.Started 2008
Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures NCT00735397Phase 3CompletedEisai Inc.Started 2008
A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures NCT00698581Phase 3TerminatedUCB PharmaStarted 2008
Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy NCT00505934Phase 2CompletedUCB Pharma SAStarted 2008
Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy NCT00504881Phase 3CompletedUCB Pharma SAStarted 2007
Pregabalin Versus Levetiracetam In Partial Seizures NCT00537238Phase 3CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.Started 2007
Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures NCT00490035Phase 3CompletedUCB Pharma SAStarted 2007
Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy NCT00535392Phase 2CompletedUCB PharmaStarted 2007
Controlled Randomized Stimulation Versus Resection (CoRaStiR) NCT00431457Not applicableCompletedUniversity Hospital, GhentStarted 2007
4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures NCT00368472Phase 2CompletedEisai Inc.Started 2006
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy NCT00280059Phase 3CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.Started 2006
Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097 NCT00310388Phase 3TerminatedGlaxoSmithKlineStarted 2006
Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903). NCT00291655Phase 3CompletedUCB PharmaStarted 2006

10 more trials match. See them on Pharma Observatory

Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy NCT02655198Status changeUnknown status to CompletedOctober 22, 2026

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.

Visit Pharma Observatory